<?xml version="1.0" encoding="UTF-8"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:content="http://purl.org/rss/1.0/modules/content/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://www.gourt.com/Health/Pharmacy/Drugs-and-Medications/I/Imatinib.html">
<title>Imatinib RSS : Gourt</title>
<link>http://www.gourt.com/Health/Pharmacy/Drugs-and-Medications/I/Imatinib.html</link>
<description></description>
<dc:language>en-us</dc:language>
<dc:rights>Copyright 2007, Gourt.com</dc:rights>
<dc:date>2012-02-09T03:00+56:00
</dc:date>
<dc:publisher>rtruog@gourt.com</dc:publisher>
<dc:creator>rtruog@gourt.com</dc:creator>
<dc:subject>Imatinib RSS : Gourt</dc:subject>
<syn:updatePeriod>hourly</syn:updatePeriod>
<syn:updateFrequency>1</syn:updateFrequency>
<syn:updateBase>1901-01-01T00:00+00:00</syn:updateBase>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://twitter.com/_DsquaredS/statuses/167449024025202688" />
  <rdf:li rdf:resource="http://twitter.com/_DsquaredS/statuses/167446926470545410" />
  <rdf:li rdf:resource="http://twitter.com/SympoOncology/statuses/167310763445334017" />
  <rdf:li rdf:resource="http://twitter.com/Woman_News/statuses/167229108714090496" />
  <rdf:li rdf:resource="http://twitter.com/RealGPSN/statuses/167179171217416192" />
  <rdf:li rdf:resource="http://twitter.com/CancerMeds1/statuses/167140262315958272" />
  <rdf:li rdf:resource="http://twitter.com/robertoperez_1/statuses/167053069559939072" />
  <rdf:li rdf:resource="http://twitter.com/emeritapons/statuses/166987655123447808" />
  <rdf:li rdf:resource="http://twitter.com/dralanteh/statuses/166843297619386368" />
  <rdf:li rdf:resource="http://twitter.com/cellsignalings/statuses/166840521422151680" />
  <rdf:li rdf:resource="http://twitter.com/Inhibitoren/statuses/166827995326185472" />
  <rdf:li rdf:resource="http://twitter.com/sogaizai/statuses/166817083215187969" />
  <rdf:li rdf:resource="http://twitter.com/inhibiteurs/statuses/166816993884905472" />
  <rdf:li rdf:resource="http://twitter.com/eogjeje/statuses/166813766816772096" />
  <rdf:li rdf:resource="http://twitter.com/inhibidordela/statuses/166810926144684033" />
 </rdf:Seq>
</items>
</channel>

<item rdf:about="http://twitter.com/_DsquaredS/statuses/167449024025202688">
<title>treatment of CML with imatinib is indefinite.. the only cure is allogenic stem cell transplant</title>
<link>http://twitter.com/_DsquaredS/statuses/167449024025202688</link>
<description><![CDATA[treatment of CML with imatinib is indefinite.. the only cure is allogenic stem cell transplant]]></description>
</item>

<item rdf:about="http://twitter.com/_DsquaredS/statuses/167446926470545410">
<title>3 drugs for CML... revolutionary imatinib.. the newer dasatinib and nalotinib</title>
<link>http://twitter.com/_DsquaredS/statuses/167446926470545410</link>
<description><![CDATA[3 drugs for CML... revolutionary imatinib.. the newer dasatinib and nalotinib]]></description>
</item>

<item rdf:about="http://twitter.com/SympoOncology/statuses/167310763445334017">
<title>Extending adjuvant imatinib treatment for high-risk gastrointestinal stromal tumors substantially boosts survival. http://t.co/TBRwwEp1</title>
<link>http://twitter.com/SympoOncology/statuses/167310763445334017</link>
<description><![CDATA[Extending adjuvant imatinib treatment for high-risk gastrointestinal stromal tumors substantially boosts survival. http://t.co/TBRwwEp1]]></description>
</item>

<item rdf:about="http://twitter.com/Woman_News/statuses/167229108714090496">
<title>Imatinib Granted Expanded Use in Patients with Rare Gastrointestinal Tumors &#xE2;&#x96;&#xBA; NCI Cancer Bulletin for February 7... http://t.co/ISIZmHJ5</title>
<link>http://twitter.com/Woman_News/statuses/167229108714090496</link>
<description><![CDATA[Imatinib Granted Expanded Use in Patients with Rare Gastrointestinal Tumors ► NCI Cancer Bulletin for February 7... http://t.co/ISIZmHJ5]]></description>
</item>

<item rdf:about="http://twitter.com/RealGPSN/statuses/167179171217416192">
<title>FDA Approved Gleevec In Rare Gastrointestinal Cancer For Expanded Use In Patients http://t.co/8INIzMpu #FDA #GISTTumors #Gleevec #Imatinib</title>
<link>http://twitter.com/RealGPSN/statuses/167179171217416192</link>
<description><![CDATA[FDA Approved Gleevec In Rare Gastrointestinal Cancer For Expanded Use In Patients http://t.co/8INIzMpu #FDA #GISTTumors #Gleevec #Imatinib]]></description>
</item>

<item rdf:about="http://twitter.com/CancerMeds1/statuses/167140262315958272">
<title>The &#x22;GIST&#x22; of it... http://t.co/xZCImilz #imatinib</title>
<link>http://twitter.com/CancerMeds1/statuses/167140262315958272</link>
<description><![CDATA[The "GIST" of it... http://t.co/xZCImilz #imatinib]]></description>
</item>

<item rdf:about="http://twitter.com/robertoperez_1/statuses/167053069559939072">
<title>RT @emeritapons: @danielkaramt URGE SU INTERVENCI&#xC3;&#x93;N. Desabasto de &#x22;Imatinib&#x22;  para la Leucemia en el SIGLO XXI  por causas burocr&#xC3;&#xA1;ticas, riesgo de muerte.</title>
<link>http://twitter.com/robertoperez_1/statuses/167053069559939072</link>
<description><![CDATA[RT @emeritapons: @danielkaramt URGE SU INTERVENCIÓN. Desabasto de "Imatinib"  para la Leucemia en el SIGLO XXI  por causas burocráticas, riesgo de muerte.]]></description>
</item>

<item rdf:about="http://twitter.com/emeritapons/statuses/166987655123447808">
<title>@danielkaramt URGE SU INTERVENCI&#xC3;&#x93;N. Desabasto de &#x22;Imatinib&#x22;  para la Leucemia en el SIGLO XXI  por causas burocr&#xC3;&#xA1;ticas, riesgo de muerte.</title>
<link>http://twitter.com/emeritapons/statuses/166987655123447808</link>
<description><![CDATA[@danielkaramt URGE SU INTERVENCIÓN. Desabasto de "Imatinib"  para la Leucemia en el SIGLO XXI  por causas burocráticas, riesgo de muerte.]]></description>
</item>

<item rdf:about="http://twitter.com/dralanteh/statuses/166843297619386368">
<title>Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION)</title>
<link>http://twitter.com/dralanteh/statuses/166843297619386368</link>
<description><![CDATA[Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION)]]></description>
</item>

<item rdf:about="http://twitter.com/cellsignalings/statuses/166840521422151680">
<title>The capabilities of a high-resolution (HR) and drugs&#x27;(dasatinib, imatinib, nilotinib&#xE2;&#x80;&#xA6; http://t.co/lcJxbL6C</title>
<link>http://twitter.com/cellsignalings/statuses/166840521422151680</link>
<description><![CDATA[The capabilities of a high-resolution (HR) and drugs'(dasatinib, imatinib, nilotinib… http://t.co/lcJxbL6C]]></description>
</item>

<item rdf:about="http://twitter.com/Inhibitoren/statuses/166827995326185472">
<title>Die F&#xC3;&#xA4;higkeiten hochaufl&#xC3;&#xB6;senden (Stunde) und drugs&#x27;(dasatinib, imatinib, nilotinib, sorafenib und sunitinib) qua... http://t.co/kQr9NehH</title>
<link>http://twitter.com/Inhibitoren/statuses/166827995326185472</link>
<description><![CDATA[Die Fähigkeiten hochauflösenden (Stunde) und drugs'(dasatinib, imatinib, nilotinib, sorafenib und sunitinib) qua... http://t.co/kQr9NehH]]></description>
</item>

<item rdf:about="http://twitter.com/sogaizai/statuses/166817083215187969">
<title>&#xE9;&#xAB;&#x98;&#xE8;&#xA7;&#xA3;&#xE5;&#x83;&#x8F;(HR)&#xE3;&#x81;&#x8A;&#xE3;&#x82;&#x88;&#xE3;&#x81;&#xB3;drugs&#x27;(&#xE3;&#x81;&#xAE;dasatinib&#xE3;&#x80;&#x81;imatinib&#xE3;&#x80;&#x81;nilotinib&#xE3;&#x80;&#x81;sorafenib&#xE3;&#x81;&#x8A;&#xE3;&#x82;&#x88;&#xE3;&#x81;&#xB3;sunitinib&#xE3;&#x81;&#xAE;)&#xE5;&#xAE;&#x9A;&#xE9;&#x87;&#x8F;&#xE5;&#x88;&#x86;&#xE6;&#x9E;&#x90;&#xE3;&#x81;&#xAE;&#xE6;&#xA9;&#x9F;&#xE8;&#x83;&#xBD;&#xE3;&#x80;&#x82;:  http://t.co/hYkEmC4P</title>
<link>http://twitter.com/sogaizai/statuses/166817083215187969</link>
<description><![CDATA[高解像(HR)およびdrugs'(のdasatinib、imatinib、nilotinib、sorafenibおよびsunitinibの)定量分析の機能。:  http://t.co/hYkEmC4P]]></description>
</item>

<item rdf:about="http://twitter.com/inhibiteurs/statuses/166816993884905472">
<title>Les possibilit&#xC3;&#xA9;s des analyses quantitatives &#xC3;&#xA0; haute r&#xC3;&#xA9;solution (heure) et de drugs&#x27;(de dasatinib, d&#x27;imatinib, de... http://t.co/dSGZ5CyL</title>
<link>http://twitter.com/inhibiteurs/statuses/166816993884905472</link>
<description><![CDATA[Les possibilités des analyses quantitatives à haute résolution (heure) et de drugs'(de dasatinib, d'imatinib, de... http://t.co/dSGZ5CyL]]></description>
</item>

<item rdf:about="http://twitter.com/eogjeje/statuses/166813766816772096">
<title>&#xEA;&#xB3;&#xA0;&#xED;&#x95;&#xB4;&#xEC;&#x83;&#x81;&#xEB;&#x8F;&#x84; (HR)&#xEC;&#x99;&#x80; drugs&#x27;(dasatinib, imatinib, nilotinib, sorafenib &#xEB;&#xB0;&#x8F; sunitinib) &#xEC;&#xA0;&#x95;&#xEB;&#x9F;&#x89; &#xEB;&#xB6;&#x84;&#xEC;&#x
